Clinic
ST Luke's Hospital
ST Luke's Hospital was paid $1.16M by Medicaid between Jan 2018 and Feb 2022, across 102 billing codes. Its largest line is 99284, emergency room visit (serious) — 14% of everything it billed.
33Billing provider infoST LUKE'S HOSPITAL
LEHIGHTON, PA 18235
LEHIGHTON, PA 18235
33aNPI1356354567assigned 08/15/2006
33bProvider typeClinic/Center
28Total paid$1.16M
24GClaims28,940
24DCodes billed102
24AFirst – last monthJan 2018 – Feb 2022
Compared with peers
Next to other Clinic/Center providers in Pennsylvania
Rank by total paid#68 of 176
Median peer was paid$441K
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 49 | $3K | |
| 2019 | 463 | $17K | |
| 2020 | 8,488 | $341K | |
| 2021 | 19,677 | $778K | |
| 2022 | 263 | $23K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 1,431 | 1,374 | $160K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 1,942 | 1,843 | $154K |
| G0378 | Hospital observation service, per hour | 13% | 183 | 162 | $150K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 866 | 807 | $133K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.7% | 1,336 | 1,276 | $90K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 6.2% | 2,604 | 594 | $71K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.7% | 739 | 716 | $55K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.4% | 297 | 289 | $52K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.7% | 830 | 830 | $43K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.8% | 370 | 346 | $21K |
| 80053 | Comprehensive metabolic panel | 1.5% | 1,805 | 1,659 | $17K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 236 | 228 | $16K |
90 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 447 | $14K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.2% | 149 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,239 | $11K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 142 | $10K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 121 | $10K |
| 80050 | General health panel | <1% | 247 | $10K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 248 | $9K |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | <1% | 139 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 954 | $9K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 111 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 270 | $6K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 30 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 146 | $5K |
| 80061 | Lipid panel | <1% | 397 | $5K |
| 71045 | Radiologic examination, chest; single view | <1% | 606 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 482 | $4K |
| 87631 | <1% | 26 | $3K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 62 | $3K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 121 | $3K |
| 83880 | <1% | 108 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 39 | $2K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 12 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 166 | $2K |
| 83735 | <1% | 339 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 267 | $2K |
| 87040 | <1% | 105 | $2K | |
| 85730 | <1% | 321 | $2K | |
| 85027 | <1% | 279 | $2K | |
| 83690 | <1% | 390 | $2K | |
| 85379 | <1% | 187 | $2K | |
| 84702 | <1% | 93 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 242 | $1K |
| 85610 | <1% | 452 | $1K | |
| 84484 | <1% | 277 | $1K | |
| 81001 | <1% | 543 | $1K | |
| 83605 | <1% | 198 | $1K | |
| 87070 | <1% | 199 | $1K | |
| 82728 | <1% | 127 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 189 | $1K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 33 | $1K |
| 73630 | <1% | 119 | $1K | |
| 81003 | <1% | 376 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 352 | $944.21 |
| 84439 | <1% | 127 | $927.89 | |
| 83540 | <1% | 121 | $909.17 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $903.31 |
| 71250 | <1% | 12 | $806.78 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 28 | $768.15 |
| 82607 | <1% | 64 | $727.58 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $719.67 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 13 | $693.02 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 24 | $647.66 |
| 90715 | <1% | 41 | $636.89 | |
| 73610 | <1% | 37 | $635.19 | |
| 73130 | <1% | 62 | $595.99 | |
| 82570 | <1% | 83 | $580.57 | |
| 73564 | <1% | 27 | $567.76 | |
| 94729 | <1% | 14 | $514.96 | |
| 94726 | <1% | 14 | $473.28 | |
| 84703 | <1% | 44 | $437.49 | |
| 85007 | <1% | 108 | $407.28 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 339 | $388.80 |
| 87186 | <1% | 57 | $385.06 | |
| 83550 | <1% | 86 | $379.31 | |
| 86140 | <1% | 153 | $369.34 | |
| 82043 | <1% | 52 | $341.58 | |
| 87077 | <1% | 43 | $309.75 | |
| 82948 | <1% | 172 | $299.56 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 700 | $284.97 |
| 82077 | <1% | 14 | $280.57 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 331 | $247.13 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 28 | $221.40 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 18 | $214.03 |
| 73110 | <1% | 15 | $196.57 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 38 | $192.83 |
| 73030 | <1% | 13 | $185.50 | |
| 85652 | <1% | 73 | $181.97 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 408 | $159.38 |
| 86901 | <1% | 42 | $151.63 | |
| 86900 | <1% | 42 | $149.80 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 54 | $142.50 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 277 | $139.90 |
| 80076 | <1% | 12 | $84.11 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 38 | $78.15 |
| 86850 | <1% | 12 | $66.34 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 15 | $37.44 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 13 | $13.41 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 15 | $12.24 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 17 | $3.52 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLICHTENWALNER, THOMAS (SENIOR VP FINANCE)
| Provider | Location | Paid |
|---|---|---|
| ST Luke's Hospital | Allentown, PA | $6.98M |
| ST Luke's Hospital | Allentown, PA | $4.97M |
| The Carbon Schuylkill Community Hospital, INC. | Tamaqua, PA | $2.00M |
| The Carbon-Schuylkill Community Hospital, INC. | Lansford, PA | $758K |
| The Carbon-Schuylkill Community Hospital, INC. | Ringtown, PA | $393K |
| GSLPG, INC | Orwigsburg, PA | $31K |
| ST. Luke's Hospital | Palmerton, PA | $607.60 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.